Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Curr Protoc Toxicol. 2016 Feb 1;67:14.13.1–14.13.27. doi: 10.1002/0471140856.tx1413s67

Table 1. Methods to Generate iPSCs.

This table summarizes the first reports of different ways to induce pluripotency, species of cells that were used, and if that method leads to transgene-free cells. This table is not an exhaustive list and is meant to be representative.

Reference Species Method Transgene-free
(Takahashi and Yamanaka, 2006) Mouse Lentivirus No
(Takahashi et al., 2007), (Yu et al., 2007) Human Lentivirus No
(Stadtfeld et al., 2008) Mouse Adenovirus Yes
(Ban et al., 2011) Human Sendai Virus Yes
(Yu et al., 2009) Human Episomal Yes
(Si-Tayeb et al., 2010b) Human Plasmid DNA Yes
(Jia et al., 2010) Human Novel ‘minicircle’ DNA Yes
(Warren et al., 2010), (Yakubov et al., 2010) Human mRNA transfection Yes
(Kim et al., 2009) Human Protein transfection Yes
(Montserrat et al., 2010) Human Poly-β-amino esters to transfect plasmids No
(Ye et al., 2010) Mouse and Human Bacteriophage ΦC31 integrase No
(Hockemeyer et al., 2008) Human Drug inducible lentivirus No
(Li et al., 2010) and (Zhao et al., 2010) Human Lentivirus delivering only Oct4, Sox2 and Nanog No
(Huangfu et al., 2008) Human Retrovirus delivering only Oct4 and Sox2 along with valproic acid treatment No
(Montserrat et al., 2011) Pig Lentivirus delivering only Sox2, Klf4 and c-Myc in feeder-free conditions No